We are live on
!
Find out more
ACM
AH Capital Management Portfolio holdings
AUM
$1.29B
1-Year Est. Return
26.81%
This Fund
S&P 500
This Quarter
Est. Return
-1.11%
1 Year Est. Return
-26.81%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.29B
AUM Growth
-$289M
(-18%)
Cap. Flow
+$36.8M
Cap. Flow
% of AUM
2.85%
Top 10 Holdings %
Top 10 Hldgs %
95.97%
Holding
17
New
4
Increased
1
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DMRA
Damora Therapeutics, Inc. Ordinary Shares
DMRA
|
+$31.8M |
| 2 |
NAVN
Navan Inc
NAVN
|
+$12.2M |
| 3 |
AKTS
Aktis Oncology
AKTS
|
+$8.06M |
| 4 |
BTGO
BitGo Holdings
BTGO
|
+$7.29M |
| 5 |
IPST
IP Strategy Holdings
IPST
|
+$76.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OMDA
Omada Health Inc
OMDA
|
+$15.9M |
| 2 |
FIG
Figma
FIG
|
+$6.44M |
| 3 |
HTBK
Heritage Commerce
HTBK
|
+$129K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 59.92% |
| 2 | Healthcare | 30.24% |
| 3 | Communication Services | 9.42% |
| 4 | Financials | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAVN
1
Navan Inc
NAVN
$6.77B
| $374M | 28.95% |
28,218,676
+1,023,312
| +4% | +$12.2M |
|
|
FIG
2
Figma
FIG
$12.9B
| $338M | 26.23% |
16,011,378
-234,751
| -1% | -$6.44M |
|
3
Meta Platforms (Facebook)
META
$1.42T
| $122M | 9.42% |
212,531
| – | – |
|
4
Revolution Medicines
RVMD
$39.9B
| $89.6M | 6.94% |
921,099
| – | – |
|
5
Nautilus Biotechnolgy
NAUT
$124M
| $68.5M | 5.31% |
17,653,917
| – | – |
|
|
XYZ
6
Block Inc
XYZ
$48.4B
| $61.2M | 4.74% |
1,016,697
| – | – |
|
|
BIOA
7
BioAge Labs
BIOA
$402M
| $56.5M | 4.38% |
3,233,170
| – | – |
|
|
MAZE
8
Maze Therapeutics
MAZE
$1.49B
| $50.8M | 3.94% |
1,702,225
| – | – |
|
9
Erasca
ERAS
$6.3B
| $46.3M | 3.59% |
2,862,500
| – | – |
|
|
DMRA
10
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.78B
| $32M | 2.48% |
+1,236,157
| New | +$31.8M |
|
|
OMDA
11
Omada Health Inc
OMDA
$1.18B
| $29M | 2.25% |
2,307,284
-1,153,645
| -33% | -$15.9M |
|
12
CAMP4 Therapeutics
CAMP
$179M
| $9.37M | 0.73% |
2,125,339
| – | – |
|
|
AKTS
13
Aktis Oncology
AKTS
$1.22B
| $7.42M | 0.58% |
+415,000
| New | +$8.06M |
|
|
BTGO
14
BitGo Holdings
BTGO
$564M
| $5.48M | 0.42% |
+666,356
| New | +$7.29M |
|
15
Ginkgo Bioworks
DNA
$528M
| $666K | 0.05% |
108,568
| – | – |
|
|
IPST
16
IP Strategy Holdings
IPST
$1.56M
| $21.8K | ﹤0.01% |
+4,137
| New | +$76.1K |
|
|
HTBK
17
DELISTED
Heritage Commerce
HTBK
| – | – |
-82,740
| Closed | -$129K |
|
Similar funds
COCM
MA
CTA
MB
MCM
GPCM
SPC
HCS
AH Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, AH Capital Management held 17 positions worth $1.29B, down 18% from $1.58B the previous quarter. Its ten largest holdings account for 96% of the portfolio.
AH Capital Management's Q1 2026 filing shows 4 new, 1 increased, 2 reduced and 1 closed positions. Its largest new stake was Damora Therapeutics, Inc. Ordinary Shares: 1,236,157 shares worth $32M. The largest sale was Omada Health Inc, an estimated $15.9M.
By sector, the portfolio is most concentrated in Technology at 60% of assets, down from 72% a quarter earlier, followed by Healthcare and Communication Services.
- AH Capital Management's largest Q1 2026 buy was Damora Therapeutics, Inc. Ordinary Shares: 1,236,157 shares worth $32M.
- AH Capital Management added most to Navan Inc in Q1 2026, an estimated $12.2M increase.
- AH Capital Management's biggest Q1 2026 reduction was Omada Health Inc, cutting an estimated $15.9M.
- AH Capital Management fully exited Heritage Commerce in Q1 2026, selling an estimated $129K.
- AH Capital Management's ten largest holdings make up 96% of its $1.29B portfolio in Q1 2026.
- AH Capital Management opened 4 new positions and closed 1 in Q1 2026.
- AH Capital Management's portfolio value fell 18% quarter-over-quarter to $1.29B.
Based on AH Capital Management's 13F filing for Q1 2026, filed 15 May 2026.